|
Viren Mehta, PharmD, Managing Member of Mehta Partners, has over thirty years of experience in the pharmaceutical and biotechnology industry, investment research, strategic advisory services, and asset management. Prior to founding Mehta and Isaly, where he pioneered an in-depth valuation methodology for biotechnology companies, Viren was a part of the strategic planning team of the International division at Merck & Co. Viren earned a Doctor of Pharmacy at the University of Southern California, and an MBA from the Anderson School of Business at the University of California, Los Angeles.
| 